Autopsy report · NCT01358331
A Study of the Safety, Tolerability, and Efficacy of MK-8353 in Participants With Advanced Solid Tumors (MK-8353-001)
Cause of deathNo reason given
Life of this trial
- Registered 6 months before it started.
- Ran for about 2 years 7 months before it stopped.
- 25 participants enrolled.
- Results were posted on the registry 5 years 10 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Merck Sharp & Dohme LLC
- Sponsor type
- Industry
- Conditions
- Tumor, Solid
- Interventions
- MK-8353
- Participants
- 25
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.